Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Meet your new digital co-workers
Opinion

Peter Griffin: Meet your new digital co-workers

Digital labour remakes the game entirely.

Peter Griffin 15 Oct 2025
The value of financial advice
Opinion

David Chaplin: The value of financial advice

Countries that banned product commissions have backtracked a little in recent years.

David Chaplin 14 Oct 2025
When the Hopium wears off
Opinion

Dileepa Fonseka: When the Hopium wears off

Whatever happened to all those green shoots?

Dileepa Fonseka 13 Oct 2025